A new class of antibiotics is offering real hope of a response to the problem of antimicrobial resistance, hitting bacteria with a dual-pronged assault that’s almost impossible to combat. Called macrolones, the drugs target two bacterial processes simultaneously – and the scientists behind a new study say this makes evolving resistance 100 million times more difficult.
AnotherLeon on
Now, what’s the quote from Jurassic Park again, that applies nicely here…
2 Comments
A new class of antibiotics is offering real hope of a response to the problem of antimicrobial resistance, hitting bacteria with a dual-pronged assault that’s almost impossible to combat. Called macrolones, the drugs target two bacterial processes simultaneously – and the scientists behind a new study say this makes evolving resistance 100 million times more difficult.
Now, what’s the quote from Jurassic Park again, that applies nicely here…